ZARS Pharma

ZARS Pharma is a specialty pharmaceutical company focused on the development and commercialization of topically administered drugs using our proprietary drug delivery technologies, primarily in the area of pain management. ZARS has two approved products and many more in various stages of development. Synera (lidocaine 70mg/tetracaine 70mg topical patch) is a topical patch designed to provide local dermal anesthesia for potentially painful superficial procedures, such as venous access procedures involving needles and immunization injections of children. Synera uses our CHADD technology and a proprietary local anesthetic formulation that contains lidocaine and tetracaine. We are commercializing Synera in the United States...

Pharmaceutical development,drug delivery,transdermal drug delivery,and topical formulations

Zars pharma operates in the Pharmaceutical manufacturing industry.

Zars pharma's revenue is 11m - 100m

Zars pharma has 11 - 50 employees.